Decreased maternal plasma apelin concentrations in preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Research
• Endocrinology

Background:

• Preeclampsia affects 3-7% of pregnancies and its pathophysiology remains unclear.
• Current treatments for preeclampsia lack broad efficacy.
• The apelinergic system is implicated in hypertensive disorders, with prior studies suggesting a role in preeclampsia.

Purpose of the Study:

• To investigate the association between plasma apelin protein concentration and preeclampsia.
• To evaluate the apelinergic system's role in preeclampsia through an epidemiological approach.

Main Methods:

• A case-control study involving pregnant women with preeclampsia (n=76) and normotensive controls (n=79).
• Plasma samples were collected at delivery and apelin peptide concentrations were measured using enzyme-linked immunosorbent assay.
• Statistical analyses were performed on the collected data.

Main Results:

• Plasma apelin concentrations were significantly lower in preeclampsia cases compared to controls (0.66 ± 0.29 vs. 0.78 ± 0.31 ng/mL, p=0.02).
• Higher plasma apelin concentrations (≥0.73 ng/mL) were associated with a 48% lower odds of preeclampsia, even after adjusting for maternal age, smoking status, and pre-pregnancy BMI.

Conclusions:

• Reduced circulating apelin peptides may be linked to preeclampsia.
• Further research into the apelinergic system is warranted to understand its role in preeclampsia and other maternal hypertensive disorders.